PADN Catheter Series
Pulmonary Hypertension (Group I, II, IV)
Commercial (China/EU) / Clinical (US)NMPA/CE Approved; FDA HUD/IDE
Key Facts
Indication
Pulmonary Hypertension (Group I, II, IV)
Phase
Commercial (China/EU) / Clinical (US)
Status
NMPA/CE Approved; FDA HUD/IDE
Company
About Pulnovo Medical
A Chinese medtech leader developing catheter-based denervation therapies for pulmonary hypertension and heart failure.
View full company profile